Clinical Trial Update: Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating Revumenib for acute leukemia in patients after allogeneic stem cell transplant; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Leukemia
• Leukemia of Ambiguous Lineage

Drugs mentioned

• Revumenib (revumenib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Acute Leukemia, Acute Leukemia of Ambiguous Lineage | Phase 1 | Status: RECRUITING